Noticias & Eventos

Seqplexing publishes its EOSAL-CNV technology in the book Methods and Molecular Biology

Compartir

Seqplexing has published a chapter in the Clinical Applications of Nucleic Acid Amplification section of the Methods and Molecular Biology book series.

Last April, Seqplexing had the pleasure of being part of volume 2621 of the Methods and Molecular Biology book series, specifically publishing the protocol "EOSAL-CNV for Easy and Rapid Detection of CNVs by Fragment Analysis" (https://doi.org/10.1007/978-1-0716-2950-5_13) in the Clinical Applications of Nucleic Acid Amplification block. This publication explains the protocol of the previously patented EOSAL-CNV technology published in Clinical Chemistry (2020 Feb 18). This technique is an alternative to MLPA for the study and characterization of CNVs.

Seqplexing

Seqplexing

Empresa biotecnológica. Desarrollo de test genéticos aplicables en clónica e investigación. Sequencing Multiplex S.L. pretende facilitar la realización de estudios genéticos con propuestas de un alto componente biotecnológico y un elevado valor añadido, de manera que se simplifiquen los procedimientos, permitan reducir los tiempos de obtención e interpretación de resultados con la máxima fiabilidad